A

Accenture

Advises businesses and runs their technology

Pharmacovigilance Services Senior Manager

Full-Time
No salary listed
Expert
Bachelor's, Master's, PharmD, PhD
Bengaluru, Karnataka, India
In Person
Biology & Biotech

About the job

Requirements
  • A Bachelor’s or Master’s degree in Pharmacy, Life Sciences, or a related field.
  • A minimum of 12 years of experience in pharmacovigilance, drug safety, or a related field, with a focus on individual case reporting, aggregate reporting, and safety signal monitoring.
  • Strong understanding of pharmacovigilance regulations, guidelines, and requirements, including ICH, FDA, and EMA.
  • Proven leadership and team management skills, with the ability to motivate and inspire cross-functional teams.
  • The ability to critically evaluate safety data.
  • The ability to collaborate with internal and external stakeholders.
Responsibilities
  • Oversee service delivery to the client, including mobilization of required resources and management of their performance.
  • Manage risks, issues, and escalations with the client ESP Management liaison.
  • Ensure efficient and compliant delivery of pharmacovigilance services and drive continuous improvement initiatives to enhance operational effectiveness and patient safety.
  • Ensure optimum deployment of people and resources to deliver business results and maintain efficiency and quality of operations.
  • Manage Team Leads and Tower Leads against individual and group performance targets and address daily issues.
  • Analyze management information systems data and take corrective action where required.
  • Work with process owners to resolve differences, define issues, organize cross-project sub-teams, and review recommendations.
  • Direct a business group or sub-division of a business group.
  • Manage budgets, resources, and project delivery and deliverables.
  • Monitor overall morale and personnel needs for the group.
  • Sign off on promotion and compensation changes.
  • Determine and lead hiring and staffing, including recruiting efforts with Recruitment and Human Resources.
  • Handle disciplinary actions and employee relations, including signing off on terminations.
  • Interact with and manage clients at all levels of the client organization.
  • Assist in leading the group in business and industry strategy.
  • Work with enabling services to ensure uptime of services, facilities, and infrastructure.
  • Work with Human Resources and recruitment to ensure timely mobilization of manpower, including defining job descriptions and selecting candidates when required.
  • Provide guidance, mentorship, and support to team members and foster accountability, collaboration, and continuous learning.
  • Set performance expectations and objectives and assess team performance against key performance indicators and service level agreements.
  • Oversee end-to-end individual case safety reporting and ensure timely and accurate submission of adverse event reports to regulatory authorities and other stakeholders.
  • Maintain project management oversight of aggregate safety reports, including Periodic Safety Update Reports and Development Safety Update Reports, in compliance with regulatory requirements.
  • Oversee monitoring and analysis of safety data to identify potential safety signals and lead their investigation and assessment.
  • Ensure compliance with pharmacovigilance regulations, guidelines, and internal policies and procedures.
  • Implement quality management systems and processes to maintain data integrity, accuracy, and completeness in pharmacovigilance activities.
  • Collaborate with cross-functional teams to address compliance or quality issues and drive corrective and preventive actions.
  • Build and maintain relationships with client and internal stakeholders to support project-level pharmacovigilance activities.
  • Identify opportunities for process optimization, automation, and standardization to improve efficiency and scalability of pharmacovigilance operations.
  • Lead or contribute to continuous improvement initiatives and drive innovation and best-practice adoption within the pharmacovigilance function.
Desired Qualifications
  • Prior experience with safety database systems such as Argus and ARISg and safety signal detection tools.
  • An advanced degree such as PharmD or PhD.

About the company

Accenture advises large businesses and public agencies on strategy, builds their technology systems and runs ongoing operations. Its teams connect business planning with implementation, covering areas such as cloud migration, cybersecurity and customer experience. Consultants work with clients to redesign processes, while engineers integrate software from technology partners and maintain the resulting systems for multinational organizations. Clients pay for project work or continuing services, including application support and business processes such as finance and customer service. Accenture was founded in 1989 and has its headquarters in Dublin, Ireland.

Company Size

10,001+

Company Stage

IPO

Headquarters

Dublin, Ireland

Founded

1989

Get referred to Accenture

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Business demand grew: October 2026 results showed $74.2 billion annual revenue, up 5% in local currency.
  • Eligible US employees buy discounted stock: Accenture's purchase plan sells shares at 15% below market price.
  • Client relationships run deep: Accenture has worked with 195 of its top 200 customers for more than ten years.

What critics are saying

  • Bookings are not guaranteed revenue: most Accenture contracts let clients cancel quickly with little or no penalty.
  • Promotions require AI adoption: Accenture's CEO said in March 2026 that employees must use its tools effectively.
  • Federal hiring practices proved costly: Accenture settled discrimination allegations for $25 million in September 2026, without a liability finding.

What makes Accenture unique

  • Its AI platform switches models: AI Refinery selects among prebuilt models according to cost, performance and other requirements.
  • Accenture owns specialist Microsoft expertise: it cofounded the Microsoft-focused Avanade consultancy with the software maker.
  • Consulting includes creative agencies: Accenture Song owns businesses spanning advertising, digital product design and customer engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • 401(k) Retirement Plan
  • 401(k) Company Match

Company News

Yahoo Finance
Oct 16th, 2026
Accenture caps staff AI spending at $29 a month after $1,000 bills

Accenture has capped employee AI spending at $29 (£21.75) a month after some staff ran up bills of $1,000, according to a report by 404 Media. The consulting firm wants to curb runaway costs as employees use AI for more everyday tasks. Companies are typically billed by usage, like a utility. Last week, some staff were told their access to Anthropic's Claude had been pulled entirely. Others are also reining in costs. Uber capped engineers' Claude spending at $1,500 a month after using up its AI budget in four months, while Microsoft has reportedly cut its Claude spending by about a third. The curbs come as Anthropic prepares for a public listing, targeting a valuation as high as $2tn. Investors are reportedly considering about $1.5tn.

Yahoo Finance
Oct 16th, 2026
Accenture's AI push: analysts see earnings reaching $10.3B by 2029 on 5.2% yearly revenue growth

Accenture is shifting AI work from pilots to deeply embedded systems, according to recent deals with UMass Memorial Health, Dell, Microsoft and Workday. The UMass Memorial project is a multi-year AI data platform, while the Dell alliance pitches private AI infrastructure to regulated clients. Analysts expect revenue to grow 5.2% a year over the next three years, with profit margins rising from 11.3% to 11.9%. They forecast earnings of $10.3 billion by 2029, up from $8.4 billion today, on revenue of $86.3 billion. The stock trades at a price-to-earnings ratio of 14.2x, against 21.9x for US IT peers. Risks include slower decision cycles in federal and EMEA work, which could curb consulting demand and margins.

Yahoo Finance
Oct 14th, 2026
Accenture plans $9.5B shareholder returns and $5B acquisitions as it bets on AI reinvention

Accenture (NYSE: ACN) is betting on enterprise AI as its main growth engine. At its Investor and Analyst Day, the company targeted at least mid-single-digit constant-currency revenue growth in fiscal 2027 and 2028, rising to mid- to high-single-digit growth from fiscal 2029. Chief executive officer Julie Sweet said AI will create new demand that exceeds work lost to automation. The company has grown its AI and data workforce from 40,000 to nearly 110,000. Accenture plans to return $9.5 billion to shareholders in fiscal 2027 and spend about $5 billion on acquisitions. It expects annual operating-margin growth of 10 to 30 basis points. Its network of specialised businesses, now 6% of revenue, could double by fiscal 2029. Fiscal 2026 revenue was $74.2 billion, up 5% in local currency.

Yahoo Finance
Oct 14th, 2026
Accenture shares up 10.4% as dividend rises to $1.71 and AI alliances with Dell and Workday expand

Accenture shares rose 10.4% after the company reported higher sales and earnings for its fourth quarter and full year in early October 2026. It confirmed fiscal 2027 guidance, raised its quarterly dividend to $1.71 per share, and completed a long-running share repurchase program. The company also expanded its AI alliances with Dell and Workday and acquired Sagacity. It aims to embed agentic AI into client functions such as HR, finance, and customer engagement. Accenture's narrative projects $86.3 billion in revenue and $10.3 billion in earnings by 2029, up from $8.4 billion today. Pricing pressure and slower discretionary spending remain the main risks.

Yahoo Finance
Oct 13th, 2026
Accenture shares up 77% from June low as Oct. 14 Investor Day nears

Accenture will hold an Investor Day on October 14, where it is expected to detail its long-term strategy, AI monetisation plans, growth guidance, and margin expansion goals. The event follows a rebound in its shares after fears that AI would erode traditional consulting work. The stock hit a low of $118.15 in June, down from a January high of $291.09. It has since gained nearly 77%, helped by fourth-quarter results on October 1 and an expanded collaboration with Dell Technologies. Fourth-quarter revenue rose 6% to $18.7 billion, and new bookings reached $22.2 billion. Accenture expects fiscal 2027 revenue growth of 3% to 6% in local currency. It raised its quarterly dividend by 5% to $1.71 per share, payable November 13, 2026. Its market capitalisation is about $139.6 billion.